Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA regulation
Research
Florey launches with plan to keep our guts in check
The company seeks to spare our guts from antibiotics using genetically modified microbes and a unique regulatory approach.
Darren Incorvaia
Oct 1, 2024 7:00am
FDA rules let recalled devices beget recalled devices: study
Jan 20, 2023 12:52pm
100% overall survival data fuel Rocket for flight to regulators
May 20, 2022 10:30am
Amryt's shares tumble as skin treatment spurned by FDA
Feb 28, 2022 11:49am
Jabra sends self-fitting hearing aids to market for $799
Feb 8, 2022 12:40pm
Gilead's CD47 hold expands as CEO expresses 'sense of urgency'
Feb 2, 2022 10:04am
